TruthArchive.ai - Related Video Feed

If a genetic sequence is injected that causes the body to manufacture a foreign protein, the body recognizes it as an invasion and launches an attack on cells. This autoimmune reaction can occur anywhere the injection lands, potentially causing myocarditis or a heart attack if it lands in the heart, stroke or neurological conditions if in the brain, blindness if in the eyes, or sterilization if in the ovaries. The body is being made to manufacture something that does not belong in it. The speaker believes the so-called vaccines encode spike proteins, which are acutely toxic to blood cells, prompting blood clots, and to nerve cells, causing them to malfunction. The body is forced to make something directly toxic, intentionally. The injectables are wrapped in lipid nanoparticles.

Dr. Pretorius and a colleague discuss unusual clotting observed after COVID-19 vaccination, including embalmers reporting back pressure when introducing embalming fluid and the extraction of very long, congealed clots—six inches to several feet—as well as patients with long brachial clots. They note thousands of clotting reports in VAERS across all vaccine types, describing these clots as not normal. Some clots cause major emboli affecting circulation to the lungs, detected by scans and perfusion studies, while others are microclots with a branching pattern visible in imaging. A clinician also shared a photo of a clot with a complete branching pattern into medium and smaller vessels. Dr. Pretorius’ work is cited to explain the mechanism: spike protein can induce immediate clumping of proteins in platelet-poor plasma in the absence of platelets, a highly unusual clotting pathway not relying on the classical coagulation cascade. This is described as a proteinaceous, pseudo-amyloid–like clot. The spike protein is reported to circulate after vaccination, with studies in the Journal of Immunology showing spikes in circulation and exosomes up to four months after shots. Long-haul COVID data (Patterson’s study) reportedly shows S1 protein present in nonclassical monocytes in blood, suggesting persistence of spike protein, whether from infection or the vaccine, which can induce clotting pathways on its own. Dr. Pretorius discusses observations of upregulation of intercellular adhesion molecules (ICAMs) on leukocytes within clots, causing white blood cells to adhere in addition to fibrin, contributing to difficulty in dissolving these clots. Concerning treatment and detection, the speakers describe depletion of plasminogen, reducing the body’s ability to break down clots, and note that standard anticoagulants are less effective against these clots, which are described as amyloid-like and atypical. They emphasize that these are not the classical clotting pathways involving platelet activation and typical thrombin–fibrin cascades. They contrast this with expectations of standard clotting mechanisms and reference the unusual, non-classical pathway highlighted by Pretorius. The discussion also mentions the idea that spike protein in circulation can drive clotting without the usual platelet activation, and that some patients have continued to experience spike-related effects long after vaccination. They assert that vaccines were developed targeting the original Wuhan strain and may not cover Omicron; they suggest the shot’s risk-benefit balance is unfavorable given ongoing clotting, immune suppression, and cancer-inducing pathways, and they claim data indicate those who receive two or three shots may acquire Omicron at a higher rate than those unvaccinated. They conclude that the shot is expired for a virus that is no longer circulating in its original form and argue that vaccination induces dangerous pathologic processes with no protective benefit.

Speaker 0: What about vaccine injury? The ones that actually took the shots. What did you see there? Speaker 1: Massive. I didn't know it was possible for a human to die so horrifically and so quickly before they rolled out the mRNA injections. It was insane. Patient the worst of them were the ones called it sepsis, but it was, like, instant multi organ failure. Like, within hours, patients would die of liver, lung, kidney, all at once failure, respiratory failure. It was like their some of the records, the emergency crew that found them, it's like their body tried to reject everything. And and some of these cases, like, their family would be there thirty minutes before, and then within an hour, they're dead. And then there were patients coming in with seizures like I've never seen before. We couldn't control some of them. Days, patients would be seizing, and no medications would stop it. And eventually, they kind of had to put down. They called it encephalitis or encephalopathy. And then later on, even the coding information organization, AHIMA, admitted COVID nineteen associated encephalitis. There were blood clots, strokes. The clots were insane. Never seen clots like that before. Even the interventional radiologist that were going in with, you know, they have angiopathies and, you know, different scopes where they can do, like, heart interventions and put stents in, like a carotid artery if you have a stroke going to your brain. They normally, it's rare to have more than one stent go in, and they were documenting, you know, multiple locations all at once. They had heart attack cases that were like that where they, you know, they needed massive amounts of stents that they never needed before. There were people in their twenties that had been hiking that were totally healthy, had been running marathons that suddenly needed an a leg amputated because they had massive blood clot going from their hip all the way down to their leg, and it couldn't be saved. So that happened. There were some cases of overnight spinal gangrene, which I've never seen before. And you can't amputate, you know, the spine when it goes gangrenous. Normally, cut out tissue that's dying like that, so it prevents further infection. And they didn't know what to do. The only thing they could do was, you know, do a basically replace the that part of your spine with an implant. That's the best they could do. Yeah. It was really intense. And I didn't question the vaccines as much as I should have. I started to about the flu shot way back in 2004. But with the pressure to get the COVID nineteen shot, I started looking into what it could do, and I I knew I didn't want anything to do with this experimental mRNA thing. And when I started looking into the experts that were saying, well, this is what this potential vaccine could do. This is what the research says. I was looking at the vaccine trials and what's happening to those patients and the Guill Barre that was happening and the strokes that were happening. And so I kind of knew to look for that when the vaccine came out. And the doctors were, you know, baffled. They weren't connecting the dots. But to me, knowing what the potential causes or potential symptoms of a vaccine injury could be, we a hundred percent had all the things that I just described. But doctors would never tell you that. They would just say it's a stroke. It's a heart attack. It's a blood clot, and they would never connect the two. Speaker 0: Is there anything that would make you take a vaccination of any kind ever again? Speaker 1: They would have to kill me. Nothing. Nothing would make me take it.

I got the vaccine. Did you really? Yeah, even the fourth one. Were you pressured into it? Kind of. I went to the doctor for blood work, and we noticed some unusual particles. I asked what they were, and the doctor revealed they were related to the vaccine. I was shocked. This is why some people experience severe issues, like having numerous white blood clots in their blood.

Genes from injected vaccines enter bloodstream and cells lining vessel walls, producing spikes. Lymphocytes attack these cells, leading to clot formation. Antibodies appear after 3-4 weeks, attacking vessel wall cells. Vaccination creates unique situation with unknown outcome. Advises against second or any future shots due to potential dangers revealed in recent publications. Calls for discussion and action to address potential risks.

The symposium covers the potential safety and threat of “replicating” vaccines, especially LepriCon (leprecon) vaccines, in the context of Covid-19 vaccines and genome‑editing concepts. The speakers present a chain of claims and concerns, some drawing on reports and others presenting theories about how these next‑generation vaccines could behave in humans and populations. Key points and claims presented - Emerging mechanisms and risks: The panel notes that blood vessel inflammation and thrombosis mechanisms are increasingly observed, including in vaccine contexts, with examples from individuals who needed limb amputation and others who developed severe vascular events after vaccination. One case involved a 70‑year‑old man who, after a third dose, developed embolic events necessitating shoulder joint surgery, and another where a 60‑year‑old man developed acute limb ischemia and died; both are presented as suggesting a serious vascular mechanism linked to vaccination, though causal connections are not established. - Replicating/vector vaccines and their concerns:荒川博士 and others discuss LepiCon vaccines as vaccines that replicate inside the body. The concept involves “replicating viral vectors” where the genome can mutate and evolve during replication. The green‑highlighted segment in a slide (the antigen gene) plus a blue/orange segment (replicating gene cassette) is used to describe how LepriCon vaccines are designed to carry viral genes and replicate, with the assertion that replication, mutation, and recombination can occur, potentially generating new variants inside the host. - Differences from conventional vaccines: The discussion contrasts LepriCon vaccines with standard mRNA vaccines. In conventional mRNA vaccines, messenger RNA is delivered and translated into antigen proteins, then degraded; in LepriCon vaccines, replicating RNA/DNA can persist and continue producing antigen, with mutation and recombination possible. The panel emphasizes that LepriCon vaccines use replicating/copying mechanisms and that the genetic material can be copied in ways that differ from natural human biology, potentially creating unpredictable variants. - Central dogma and exceptions: The speakers reference the central dogma (DNA → RNA → protein) but note exceptions in viruses, including RNA viruses that can reverse‑transcribe to DNA (retroviruses) and RNA viruses that replicate RNA directly. They discuss how LepriCon vaccines would rely on replicative processes that do not follow the usual linear flow and why this could complicate predictions about safety and behavior in humans. - Potential for unintended spread and environmental impact: A major concern raised is that self‑replicating vectors could spread beyond the vaccinated individual, via exosomes or other intercellular transport, creating secondary infections or non‑target spread. Exosomes could ferry replicating genetic material, raising fears of new infection chains or “outbreaks” stemming from the vaccine itself, and even suggesting the possibility of vaccination‑induced spread akin to an attenuated or modified pathogen. - Safety signals and immunology concerns: The discussion touches on immune system risks, including immune dysregulation, autoimmune phenomena, and unexpected inflammatory responses. IGG4‑related disease is highlighted as a potential adverse outcome post‑vaccination, with descriptions of glandular and systemic involvement and the idea that high IGG4 levels could have immunosuppressive effects that alter responses to infection or vaccination. The panel notes observed increases in certain immunoglobulin subclasses after multiple LepriCon doses and discusses the possibility of immune tolerance or enhanced immune responses that could be harmful. - Historical and theoretical context: References are made to past epidemics and speculative pandemics caused by misused or dangerous vaccine platforms, drawing on central molecular biology concepts and historical anecdotes about how vaccines can be designed and misused. The discussion frames LepriCon vaccines as a high‑risk platform that could, in theory, generate recombinants, escape mutations, or cause unintended immune and inflammatory consequences. - Clinical and regulatory implications: The speakers call for caution, arguing that more evidence is needed before approving or widespread use of LepriCon vaccines. They emphasize the need for long‑term observation and transparent communication about risks, and criticize the potential for insufficient understanding among healthcare workers and the public. They also urge that any future vaccine development should consider the possibility of genome editing, recombination, and exosome‑mediated spread, and stress the importance of not underestimating possible adverse effects. - Real‑world observations and skepticism about hype: Several speakers underscore that the danger is not merely hypothetical; there are reports of adverse events, including stroke‑like conditions, inflammatory diseases, and immune dysregulation in vaccinated individuals. They stress that the evolution and mutation of replicating vaccines could outpace current surveillance methods, and that “information manipulation” or lack of transparent reporting could mislead the public about risks. - Final reflections and call to action: The concluding messages advocate recognizing the potential failures of messenger RNA vaccines and acknowledging that both conventional and replicating platforms may carry risks. The speakers urge ongoing critical analysis, cautious progression, and robust verification of claims through transparent, independent investigation. They close with thanks to the organizers and a hope that the discussion may contribute to broader public awareness and informed decision‑making. Notable emphasis and unique considerations - The core concern centers on LepriCon vaccines’ replication, mutation, and potential to spread beyond the vaccinated person; exosome transport and genomic/cellular integration are highlighted as mechanisms that could generate new risks not present with non‑replicating vaccines. - The discussion stresses that IGG4 responses could become alarmingly high after certain doses, potentially leading to immunosuppressive effects or autoimmune phenomena, and presents IGG4‑related disease as a potential complication to monitor. - The speakers insist that safety and transparency are paramount, and that misinformation or optimistic narratives about rapid vaccine development could lead to harm if new platforms are adopted without comprehensive evaluation. Overall, the symposium foregrounds cautious scrutiny of replicating vaccine platforms, frames potential biological and regulatory risks, and calls for careful, evidence‑based assessment before broader deployment.

There have been reports of blood clots in patients who have received the vaccine. These clots have been found in living patients and have also been observed in post-mortem examinations. The clots are made up of fibrous material and unusual combinations of proteins that make them difficult for the body to dissolve. However, it is important to note that not everyone who receives the vaccine will experience these clots. One possible solution is the use of an enzyme called Nattokinase, derived from fermented soy, which has been shown to break down fibrin and dissolve clots. Further research is needed to fully understand and address this issue.

There are 3,400 peer-reviewed papers in the National Library of Medicine that describe fatal and nonfatal vaccine injury syndromes. These vaccines cause real side effects in four major categories: cardiovascular issues like heart inflammation and cardiac arrest, neurologic problems such as stroke and neuropathy, unprecedented blood clotting that doesn't respond to usual treatments, and immune system abnormalities.

The CDC is investigating potential links between the COVID vaccine and strokes in patients who have received the vaccine. There have been cases of people suffering from strokes after getting vaccinated.

The speaker discusses how the spike protein in vaccines can lead to clotting issues, immune suppression, and reactivation of latent viruses like mono. This can also weaken the body's ability to fight off other viruses and cancers. An increase in cancer cases post-vaccination is noted anecdotally. The speaker attributes these effects to the spike protein in the vaccines.

Speaker 0 states that the study confirms suspicions from the past five years that common sense has deteriorated in the population. The study analyzed the VAERS system from the 1990s to 2024 and examined PRRs (proportional reporting ratios), which measure how many more adverse events occur with the COVID shots compared to the flu shot or other vaccines. It reports 8686 safety signals of neuropsychiatric adverse events, with some up to 3,000 times higher than the flu shot. The safety signal threshold defined by CDC/FDA for PRRs is greater than two, and all reported signals exceeded this threshold. The listed conditions include schizophrenia, dementia, Alzheimer's, cognitive impairment, strokes, brain clots, homicidal tendencies, homicidal behavior, and psychosis, described as people hallucinating and brain damage. The speaker notes that this large number of safety signals aligns with a recent study indicating that people who had strokes showed toxic spike protein production in their brains for up to seventeen months after vaccination, which the speaker suggests explains the observed deterioration in cognitive function.

In the past, we did not see blood clotting like this before COVID-19 vaccinations. A marathon runner had severe issues walking after vaccination, requiring treatments like plasma freezes. Clot formations indicate ongoing damage to blood vessel linings, leading to clot formation. Multiple vaccinated individuals experience circulation problems in cold temperatures, with symptoms improving in warmer weather.

There are over 3,400 peer-reviewed papers in the National Library of Medicine that describe fatal and non-fatal vaccine injury syndromes. These vaccines have real side effects in four major categories: cardiovascular issues like heart inflammation and cardiac arrest, neurologic problems such as stroke and neuropathy, unprecedented blood clotting that doesn't respond to usual treatments, and immune system abnormalities.

Checklist for summary approach: - Identify the core topic: vaccine-induced immune thrombotic events leading to stroke in healthy people after 2021. - Capture sequence and timeline: old-stroke stereotype, new observations in healthy individuals, studies tracing patterns weeks after certain shots. - Explain mechanism as described: immune system overreacts, the protective spike sticks to vessel walls, causing ischemia. - Note terminology and sources: “vaccine induced immune thrombotic events,” rarity, and citations to Lancet and NEGM. - Identify proposed causes: genetics, guts, toxins, or a combination. - Emphasize the concluding point: misfiring immune response can lead to stroke; focus is on understanding why, not disputing occurrence. - Preserve original phrasing where it conveys key claims, while translating into a cohesive English summary. - Exclude evaluative or judgmental statements; present claims as stated. - Keep the final summary within 368-461 words. Summary: They said stroke only happened to the old, but hospitals started seeing something new. Healthy people suddenly clotting. Coincidence? Maybe. But after 2021, studies began tracing small patterns weeks after certain shots. Most never notice but for a few, the immune system hits too hard. The same spike that's meant to protect starts sticking to vessel walls. Breath thickens, flow slows. Boom. Ischaemia. Doctors call it vaccine induced immune thrombotic events. Rare. Yes. Imagine. No. It's in the Lancet and NEGM. The question isn't if it happens but why somebody's break the code. Genetics, guts, toxins, maybe all three. Because when the system builds to defend starts to misfire the result isn't protection, it's a stroke.

The data indicates that vaccinations have led to serious health issues, including blood clots, strokes, and amputations. A simple d-dimer test can reveal the presence of blood clots, yet the government has not mandated this test for vaccinated individuals. Studies by two cardiologists found that over 80% of vaccinated patients had elevated d-dimer levels, suggesting microemboli, which can cause gradual organ failure and increase the risk of severe thrombosis, particularly in the brain. Cases of thrombosis in young people are rising, likely due to microemboli and the spike protein from the vaccine affecting blood vessel walls. This connection has been established through clinical observations.

"Now, when these genes, packages, enter the cells, then the cells will start making this damn virus protein which is called the spike." "This is going to happen to any mRNA or gene based vaccine." "Those packages are going to cause your cells in the blood vessels to create this protein and this protein is going to be a foreign non self protein that is going to be recognised by any antibodies that you have and these antibodies are going to be there after the first injection." "If any of these vessels is clogged because of a thrombus or because it's injured, the cells that are being supplied by oxygen are going to die." "So if these tiny vessels in the brain or the heart are damaged, you are damaged for life. You will never be the same again."

The speaker observed vasculitis, or inflammation of the blood vessels, in the brain tissue of almost all cases examined post-vaccination. Lymphocytes aggregate around small vessels, indicating inflammation possibly triggered by an antigenic structure like spike protein. This was described as one of the most alarming findings. Individuals with this complication may experience transient defects like loss of speech, unconsciousness, or blindness, but the brain can compensate if there is no major inflammation or hemorrhage. The speaker clarified that the individuals did not die from the vasculitis itself. It's possible for vaccinated individuals to experience these symptoms without knowing the underlying cause. Changes in character have been reported in some vaccinated individuals, which may be related to this inflammation.

The spike protein, according to research in South Africa, induces fibrin from fibrinogen, forming the backbone of clotting in a way not previously seen. Unlike normal fibrin clots that are easily broken down, clots formed from COVID or the spike protein from the vaccine are difficult to break down, causing issues for many people. A cardiologist stated that in their decades of practice, they have never treated as many blood clots as in the last five years. These blood clots occur after the virus infection and the vaccine because the spike protein causes blood clots. Therefore, it is reckless to continue vaccinating people and loading the body with spike protein, causing more blood clots. According to a paper in Cell (July 2021), the nucleoprotein, not the spike protein, supplied broad and durable immunity for the prevention of infection. The speaker questions why the vaccine wasn't changed to target the nucleoprotein once this information came to light.

Truth is out. Scientists are now confirming what many have long suspected. The COVID shots don't just impact your immune system. They can damage your brain and devastate mental health, and the evidence is overwhelming. A recent wave of studies have revealed shocking increases in ischemic strokes up forty four percent, hemorrhagic strokes up fifty percent, transient ischemic strokes or mini strokes up sixty seven percent, myasthenia gravis, a debilitating autoimmune condition up over seventy one percent, Alzheimer's up twenty two percent, cognitive impairment up nearly a hundred and thirty eight percent, depression up over sixty eight percent, anxiety disorders up nearly forty four percent, and sleep disorders up over ninety three percent, all linked to one thing, toxic spike protein accumulation and persistence in the brain. This isn't a conspiracy theory. There's a documented peer reviewed research published studies by documented experts, including by epidemiologist Nicholas Holcher, who says using mRNA to hijack cells in various organ systems to produce a highly toxic spike protein that persists in the body for months or even years was one of the worst ideas in medical history. So what can you do?

I found many clinicians dismissing the importance of asking about vaccination status when treating patients with blood clots. Despite frustrations, I continue to see cases where this information is overlooked. Collaborating with physicians in Birmingham, we witnessed an increase in severe cases, including young individuals with atrial fibrillation. I made the decision to prioritize patient care over job security, treating over 2,000 patients, including those with vaccine injuries.

Residual effects from one or two COVID shots can include late blood clots and cardiac arrests years later. The mRNA and spike protein from the shots can linger in the body, causing various health issues like heart and brain damage, blood clots, and immunologic problems. A spike detox program is recommended to address these concerns.

The speaker asserts that COVID-19 shots do more than affect the immune system; they can damage the brain and worsen mental health. They claim a wave of studies shows sharp increases in various strokes: ischemic strokes up to 44%, hemorrhagic strokes up to 50%, and transient ischemic attacks (mini strokes) up to 67%. They also report increases in neurological and autoimmune conditions, including myasthenia gravis up 71% and Alzheimer’s disease up 22%. Cognitive impairment is claimed to have risen by nearly 138%, while depression is up 68%, anxiety disorders up 44%, and sleep disorders up 93%. The speaker links all of these increases to “toxic spike protein accumulation and persistence in the brain.” The speaker states this is not a conspiracy theory and cites what they describe as documented peer‑reviewed research and studies by experts. They name epidemiologist Nicholas Holcher, who allegedly says that using mRNA to hijack cells in various organ systems to produce a highly toxic spike protein that persists in the body for months or years was “one of the worst ideas in medical history.” The speaker then asks, “So what can you do?” as a transition to presumably recommendations or actions, though no specific actions are listed in the provided segment.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

There are over 3,400 peer-reviewed papers in the National Library of Medicine that describe fatal and nonfatal vaccine injury syndromes. These vaccines cause real side effects in four major categories: cardiovascular issues like heart inflammation and cardiac arrest, neurologic problems such as stroke and neuropathy, unprecedented blood clotting that doesn't respond to usual treatments, and abnormalities in the immune system.

The speaker claims injections result in blood clots, stroke, heart attack, and lost limbs, and questions why the government hasn't ordered D-dimer tests for vaccinated individuals to assess blood clot risk. Two cardiology studies allegedly found over 80% of vaccinated patients had high D-dimer levels, indicating microemboli. Microemboli in the brain, heart, or kidneys can cause organ failure and increase susceptibility to disease, potentially leading to strokes. The speaker reports seeing more cases of thrombosis of the superior sagittal sinus and transverse sinus in the brain, particularly in young people. They attribute this to microemboli and embolism caused by the spike protein from the vaccine and a nanolipid carrier entering the blood vessel wall, which they claim has been proven.